活体肾捐献者30年长期结局:瑞士多中心前瞻性队列研究
该研究基于瑞士器官活体捐献者健康登记库,纳入1993—2018年1863例随访≥5年的活体肾捐献者,中位随访12年。捐献后肾功能总体稳定,年均eGFR变化+0.14 ml/min per 1.73 m2;仅0.2%进展至透析依赖肾衰竭,2.1%达到复合终点。男性、年龄和捐献前肥胖独立预测复合终点,支持捐献安全性但需标准化长期监测。
要点
- 活体肾捐献后长期肾功能总体稳定,年均eGFR变化+0.14 ml/min per 1.73 m2。
- 透析依赖肾衰竭发生率0.2%,复合终点发生率2.1%,支持捐献安全性。
- 男性、年龄和捐献前肥胖独立预测复合终点,肥胖和高血压者eGFR斜率减弱。
核心结论
- 活体肾捐献者长期结局总体安全,但需标准化长期监测以优化捐献者照护与咨询。
研究设计与样本
- 前瞻性多中心队列研究,使用瑞士器官活体捐献者健康登记库数据。
- 纳入1863例1993—2018年活体肾捐献者,随访≥5年,随访至死亡、肾衰竭或末次访视(截尾2024年3月31日)。
- 采用线性混合效应模型分析捐献后12个月起的肾功能轨迹。
主要发现
- 中位年龄53岁,女性66.2%,捐献前接受治疗的高血压占15.5%,捐献前eGFR中位数96 ml/min per 1.73 m2,1%捐献前eGFR<60 ml/min per 1.73 m2。
- 中位随访12年(IQR 7–18年),肾功能保持稳定,年均eGFR变化+0.14 ml/min per 1.73 m2。
- 女性、非肥胖及无捐献前高血压者eGFR斜率更稳定,肥胖和高血压捐献者斜率减弱;年龄和捐献前eGFR未见差异。
- 3例(0.2%)进展至透析依赖肾衰竭,17例(0.9%)eGFR<30 ml/min per 1.73 m2,28例(1.5%)持续严重蛋白尿,40例(2.1%)达到复合终点。
- 男性、年龄和捐献前肥胖独立预测复合终点。
临床怎么用
- 咨询活体肾捐献者时可告知长期肾功能总体稳定、透析依赖肾衰竭风险约0.2%。
- 对捐献前肥胖或高血压的捐献者,应加强长期肾功能监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Living kidney donor transplantation provides major benefits for recipients, but long-term donor safety remains a critical concern. METHODS: We conducted a prospective, multicenter cohort study using data from the Swiss Organ Living-Donor Health Registry. A total of 1863 living kidney donors (1993-2018) with ≥ 5 years of follow-up were followed until death, kidney failure (KF), or last visit (censoring March 31, 2024). Kidney function trajectories from 12 months postdonation onward were analyzed using linear mixed-effects models. A composite secondary end point included early death, dialysis-dependent KF, estimated glomerular filtration rate (eGFR) < 30 ml/min per 1.73 m2, or persistent proteinuria. Risk factors were assessed. RESULTS: A total of 1863 living kidney donors (median age 53 years, 66.2% female) were included; 15.5% had treated arterial hypertension before donation. Median predonation eGFR was 96 ml/min per 1.73 m2, 1% had an eGFR < 60 ml/min per 1.73 m2. Median follow-up was 12 years (interquartile range [IQR]: 7-18 years). Kidney function remained stable, with an average annual eGFR change of +0.14 ml/min per 1.73 m2. Slopes differed by donor characteristics, as follows: women, nonobese, and those without predonation hypertension presented with more stable slopes, whereas obese and hypertensive donors showed attenuated slopes. No differences were observed by age or predonation eGFR. Three donors (0.2%) progressed to dialysis-dependent KF. Overall, 17 donors (0.9%) developed an eGFR < 30 ml/min per 1.73 m2, 28 (1.5%) developed persistent severe proteinuria, and 40 (2.1%) reached the combined end point. Male sex, age, and predonation obesity independently predicted the combined endpoint. CONCLUSION: These findings support safety while underscoring the need for standardized long-term surveillance to optimize donor care and counseling.
引用
- Krättli J, Buess D, Flohr M, et al. Long Term Outcomes in Living Kidney Donors Over 30 Years. Kidney Int Rep. 2026. PMID: 42569397. doi:10.1016/j.ekir.2026.106690
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。